BG108415A - Anthranilic acid amides with a heteroarylsulphonyl side chain, method for the preparation thereof, their use as medicamentous or diagnostical form and pharmaceutical preparations containing the said compounds. - Google Patents

Anthranilic acid amides with a heteroarylsulphonyl side chain, method for the preparation thereof, their use as medicamentous or diagnostical form and pharmaceutical preparations containing the said compounds.

Info

Publication number: BG108415A
Authority: BG; Bulgaria
Prior art keywords: compounds; heteroarylsulphonyl; diagnostical; medicamentous; preparation
Prior art date: 2001-06-12

Application number

BG108415A

Other languages

Bulgarian (bg)

English (en)

Inventor

Joachim Brendel

Thomas Boehme

Stefan Peukert

Heinz-Werner Kleemann

Original Assignee

Aventis Pharma Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-12

Filing date

2003-12-04

Publication date

2004-07-30

2003-12-04 Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh

2004-07-30 Publication of BG108415A publication Critical patent/BG108415A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/12—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Heart & Thoracic Surgery (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Pyridine Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

BG108415A 2001-06-12 2003-12-04 Anthranilic acid amides with a heteroarylsulphonyl side chain, method for the preparation thereof, their use as medicamentous or diagnostical form and pharmaceutical preparations containing the said compounds. BG108415A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10128331A DE10128331A1 (de)	2001-06-12	2001-06-12	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
PCT/EP2002/005956 WO2002100825A2 (fr)	2001-06-12	2002-05-31	Amides d'acide anthranilique comportant une chaine laterale heteroarylsulfonyle, procede de fabrication, utilisation en tant qu'agent pharmaceutique ou diagnostique, et preparations pharmaceutiques contenant ces amides

Publications (1)

Publication Number	Publication Date
BG108415A true BG108415A (en)	2004-07-30

Family

ID=7687941

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG108415A BG108415A (en)	2001-06-12	2003-12-04	Anthranilic acid amides with a heteroarylsulphonyl side chain, method for the preparation thereof, their use as medicamentous or diagnostical form and pharmaceutical preparations containing the said compounds.

Country Status (41)

Country	Link
US (2)	US6903216B2 (fr)
EP (1)	EP1399423B9 (fr)
JP (1)	JP4422477B2 (fr)
KR (1)	KR100863924B1 (fr)
CN (1)	CN1247544C (fr)
AR (1)	AR036045A1 (fr)
AT (1)	ATE378318T1 (fr)
AU (1)	AU2002316939B2 (fr)
BG (1)	BG108415A (fr)
BR (1)	BR0210374A (fr)
CA (1)	CA2450076C (fr)
CO (1)	CO5540283A2 (fr)
CR (1)	CR7140A (fr)
CY (1)	CY1107427T1 (fr)
CZ (1)	CZ20033361A3 (fr)
DE (2)	DE10128331A1 (fr)
DK (1)	DK1399423T3 (fr)
EC (1)	ECSP034883A (fr)
EE (1)	EE05196B1 (fr)
ES (1)	ES2295360T3 (fr)
HK (1)	HK1065316A1 (fr)
HR (1)	HRP20031028A2 (fr)
HU (1)	HUP0400159A3 (fr)
IL (2)	IL159247A0 (fr)
MA (1)	MA27037A1 (fr)
MX (1)	MXPA03010875A (fr)
MY (1)	MY138341A (fr)
NO (1)	NO20035450D0 (fr)
NZ (1)	NZ530081A (fr)
OA (1)	OA12631A (fr)
PE (1)	PE20021066A1 (fr)
PL (1)	PL364371A1 (fr)
PT (1)	PT1399423E (fr)
RS (1)	RS97703A (fr)
RU (1)	RU2293727C2 (fr)
SK (1)	SK15222003A3 (fr)
TN (1)	TNSN03134A1 (fr)
TW (1)	TWI304400B (fr)
UA (1)	UA75412C2 (fr)
WO (1)	WO2002100825A2 (fr)
ZA (1)	ZA200308520B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10128331A1 (de) *	2001-06-12	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
US7119112B2 (en) *	2002-02-28	2006-10-10	Icagen, Inc.	Sulfonamides as potassium channel blockers
BR0309522A (pt) *	2002-04-26	2005-02-09	Ishihara Sangyo Kaisha	Compostos piridina ou sais destes e herbicidas contendo os mesmos
EP1388535A1 (fr) *	2002-08-07	2004-02-11	Aventis Pharma Deutschland GmbH	Arylcycloalkylamines acylés et leurs utilisations comme produits pharmaceutiques
DE10312061A1 (de) *	2003-03-18	2004-09-30	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit Blockern des IK-Kanals und deren Verwendung zur Behandlung von Vorhofarrhythmien
GB0315950D0 (en)	2003-06-11	2003-08-13	Xention Discovery Ltd	Compounds
EP1489071A1 (fr) *	2003-06-18	2004-12-22	4Sc Ag	Dérivés de 3,4-dihydro-1H-isoquinoline N-substitués utilisés comme modulateurs de canaux de potassium
DE602004015614D1 (de)	2003-08-08	2008-09-18	Janssen Pharmaceutica Nv	2- (chinoxalin-5-ylsulfonylamino) -benzamidverbindungen als cck2-modulatoren
DE10341233A1 (de) *	2003-09-08	2005-03-24	Aventis Pharma Deutschland Gmbh	Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
DE102004009931A1 (de) *	2004-02-26	2005-09-15	Aventis Pharma Deutschland Gmbh	Kv1.5-Blocker zur selektiven Steigerung der Vorhofkontraktilität und Behandlung der Herzinsuffizienz
GB0412986D0 (en)	2004-06-10	2004-07-14	Xention Discovery Ltd	Compounds
US7569589B2 (en)	2004-07-29	2009-08-04	Merck & Co., Inc.	Potassium channel inhibitors
AU2005289887A1 (en)	2004-09-24	2006-04-06	Janssen Pharmaceutica, N.V.	Sulfonamide compounds
US7576212B2 (en)	2004-12-09	2009-08-18	Xention Limited	Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0525164D0 (en)	2005-12-09	2006-01-18	Xention Discovery Ltd	Compounds
KR101390239B1 (ko) *	2006-04-27	2014-04-30	사노피-아벤티스 도이칠란트 게엠베하	Ｔａｓｋ-1 및 ｔａｓｋ-3 이온 채널 억제제
WO2008124524A2 (fr) *	2007-04-03	2008-10-16	Janssen Pharmaceutica N.V.	Composés de sulfonamide d'aryle comme modulateurs de récepteur cck2
GB0815784D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815782D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
GB0815781D0 (en)	2008-08-29	2008-10-08	Xention Ltd	Novel potassium channel blockers
SG177434A1 (en)	2009-06-29	2012-02-28	Agios Pharmaceuticals Inc	Therapeutic compounds and compositions
EP2448909B1 (fr) *	2009-06-29	2013-05-01	Merz Pharma GmbH & Co. KGaA	Procédé de préparation de 1-amino-1, 3,3,5,5-pentaméthylcyclohexane
WO2011010132A1 (fr) *	2009-07-21	2011-01-27	Astrazeneca Ab	Composé 600
FR2967674B1 (fr) *	2010-11-23	2012-12-14	Pf Medicament	Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine
GB201105659D0 (en)	2011-04-01	2011-05-18	Xention Ltd	Compounds
NO3175985T3 (fr)	2011-07-01	2018-04-28
WO2013112932A1 (fr)	2012-01-27	2013-08-01	Gilead Sciences, Inc.	Thérapies de combinaison à l'aide de bloqueurs de canaux ioniques au sodium tardifs et de bloqueurs de canaux ioniques au potassium
US9701627B2 (en) *	2014-06-16	2017-07-11	University Of Maryland, Baltimore	LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
WO2019031472A1 (fr) *	2017-08-07	2019-02-14	国立大学法人広島大学	NOUVEAU COMPOSÉ À BASE D'ACIDE ANTHRANILIQUE, ET INHIBITEUR DE Pin1, AGENT THÉRAPEUTIQUE CONTRE LES MALADIES INFLAMMATOIRES AINSI QU'AGENT THÉRAPEUTIQUE CONTRE LE CANCER METTANT EN ŒUVRE CELUI-CI

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5716993A (en)	1993-12-27	1998-02-10	Eisai Co., Ltd.	Anthranilic acid derivatives
US5670504A (en)	1995-02-23	1997-09-23	Merck & Co. Inc.	2,6-diaryl pyridazinones with immunosuppressant activity
US6083986A (en)	1996-07-26	2000-07-04	Icagen, Inc.	Potassium channel inhibitors
DK173062B1 (da)	1996-10-11	1999-12-13	Krueger As I	Fremgangsmåde til fjernelse af opløste metaller og/eller metalloider fra et vandigt medium indeholdende samme og med et sto
US5935945A (en)	1996-10-31	1999-08-10	Merck & Co., Inc.	Methods of treating or preventing cardiac arrhythmia
US5969017A (en)	1996-10-31	1999-10-19	Merck & Co., Inc.	Methods of treating or preventing cardiac arrhythmia
TW523506B (en)	1996-12-18	2003-03-11	Ono Pharmaceutical Co	Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
BR9911914B1 (pt)	1998-07-08	2010-10-19		n-arilamidas do ácido sulfonilaminocarboxìlico substituìdas por enxofre, processo para sua preparação, bem como preparações farmacêuticas que compreendem as mesmas.
WO2000012077A1 (fr) *	1998-09-01	2000-03-09	Bristol-Myers Squibb Company	Inhibiteurs de canaux potassium et leur methode d'utilisation
CN1358062A (zh) *	1999-06-24	2002-07-10	史密丝克莱恩比彻姆公司	巨噬细胞清除剂受体拮抗剂
DE19947457A1 (de) *	1999-10-02	2001-04-05	Aventis Pharma Gmbh	2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US6531495B1 (en) *	1999-10-02	2003-03-11	Aventis Pharma Deutschland Gmbh	2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
DE10128331A1 (de) *	2001-06-12	2002-12-19	Aventis Pharma Gmbh	Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

2001
- 2001-06-12 DE DE10128331A patent/DE10128331A1/de not_active Withdrawn
2002
- 2002-05-17 PE PE2002000419A patent/PE20021066A1/es not_active Application Discontinuation
- 2002-05-21 OA OA1200300333A patent/OA12631A/fr unknown
- 2002-05-31 JP JP2003503594A patent/JP4422477B2/ja not_active Expired - Fee Related
- 2002-05-31 HU HU0400159A patent/HUP0400159A3/hu unknown
- 2002-05-31 CA CA2450076A patent/CA2450076C/fr not_active Expired - Fee Related
- 2002-05-31 CN CNB028118502A patent/CN1247544C/zh not_active Expired - Fee Related
- 2002-05-31 EE EEP200300558A patent/EE05196B1/xx not_active IP Right Cessation
- 2002-05-31 MX MXPA03010875A patent/MXPA03010875A/es active IP Right Grant
- 2002-05-31 WO PCT/EP2002/005956 patent/WO2002100825A2/fr active IP Right Grant
- 2002-05-31 AU AU2002316939A patent/AU2002316939B2/en not_active Ceased
- 2002-05-31 DE DE50211213T patent/DE50211213D1/de not_active Expired - Lifetime
- 2002-05-31 AT AT02745333T patent/ATE378318T1/de active
- 2002-05-31 SK SK1522-2003A patent/SK15222003A3/sk unknown
- 2002-05-31 NZ NZ530081A patent/NZ530081A/en unknown
- 2002-05-31 IL IL15924702A patent/IL159247A0/xx unknown
- 2002-05-31 CZ CZ20033361A patent/CZ20033361A3/cs unknown
- 2002-05-31 BR BR0210374-5A patent/BR0210374A/pt not_active Application Discontinuation
- 2002-05-31 PL PL02364371A patent/PL364371A1/xx not_active IP Right Cessation
- 2002-05-31 KR KR1020037016206A patent/KR100863924B1/ko not_active IP Right Cessation
- 2002-05-31 RS YU97703A patent/RS97703A/sr unknown
- 2002-05-31 PT PT02745333T patent/PT1399423E/pt unknown
- 2002-05-31 ES ES02745333T patent/ES2295360T3/es not_active Expired - Lifetime
- 2002-05-31 UA UA2004010206A patent/UA75412C2/uk unknown
- 2002-05-31 DK DK02745333T patent/DK1399423T3/da active
- 2002-05-31 EP EP02745333A patent/EP1399423B9/fr not_active Expired - Lifetime
- 2002-05-31 RU RU2004100302/04A patent/RU2293727C2/ru not_active IP Right Cessation
- 2002-06-10 TW TW091112464A patent/TWI304400B/zh not_active IP Right Cessation
- 2002-06-10 AR ARP020102178A patent/AR036045A1/es active IP Right Grant
- 2002-06-11 MY MYPI20022165A patent/MY138341A/en unknown
- 2002-06-12 US US10/166,595 patent/US6903216B2/en not_active Expired - Lifetime
2003
- 2003-07-08 TN TNPCT/EP2002/005956A patent/TNSN03134A1/en unknown
- 2003-10-31 ZA ZA200308520A patent/ZA200308520B/en unknown
- 2003-11-04 CR CR7140A patent/CR7140A/es not_active Application Discontinuation
- 2003-12-03 EC EC2003004883A patent/ECSP034883A/es unknown
- 2003-12-04 BG BG108415A patent/BG108415A/xx unknown
- 2003-12-08 IL IL159247A patent/IL159247A/en not_active IP Right Cessation
- 2003-12-08 NO NO20035450A patent/NO20035450D0/no not_active Application Discontinuation
- 2003-12-10 MA MA27434A patent/MA27037A1/fr unknown
- 2003-12-11 HR HR20031028A patent/HRP20031028A2/hr not_active Application Discontinuation
- 2003-12-11 CO CO03108701A patent/CO5540283A2/es not_active Application Discontinuation
2004
- 2004-10-20 HK HK04108195A patent/HK1065316A1/xx not_active IP Right Cessation
2005
- 2005-02-08 US US11/052,959 patent/US7235664B2/en not_active Expired - Lifetime
2008
- 2008-02-04 CY CY20081100143T patent/CY1107427T1/el unknown

Also Published As

Publication number	Publication date
IL159247A (en)	2010-06-16
US7235664B2 (en)	2007-06-26
JP2004533464A (ja)	2004-11-04
AU2002316939B2 (en)	2006-11-23
KR100863924B1 (ko)	2008-10-17
SK15222003A3 (sk)	2004-06-08
MY138341A (en)	2009-05-29
NZ530081A (en)	2005-07-29
IL159247A0 (en)	2004-06-01
MA27037A1 (fr)	2004-12-20
DE10128331A1 (de)	2002-12-19
CA2450076A1 (fr)	2002-12-19
OA12631A (fr)	2006-06-14
BR0210374A (pt)	2004-07-13
KR20040030668A (ko)	2004-04-09
HK1065316A1 (en)	2005-02-18
AR036045A1 (es)	2004-08-04
PT1399423E (pt)	2008-02-07
MXPA03010875A (es)	2004-02-17
EP1399423B1 (fr)	2007-11-14
NO20035450D0 (no)	2003-12-08
CO5540283A2 (es)	2005-07-29
US6903216B2 (en)	2005-06-07
CN1529695A (zh)	2004-09-15
ECSP034883A (es)	2004-01-28
TNSN03134A1 (en)	2005-12-23
TWI304400B (en)	2008-12-21
PL364371A1 (en)	2004-12-13
WO2002100825A2 (fr)	2002-12-19
EP1399423B9 (fr)	2008-02-27
DK1399423T3 (da)	2008-03-17
CN1247544C (zh)	2006-03-29
HRP20031028A2 (en)	2005-10-31
US20030114499A1 (en)	2003-06-19
JP4422477B2 (ja)	2010-02-24
EP1399423A2 (fr)	2004-03-24
HUP0400159A3 (en)	2008-10-28
RU2293727C2 (ru)	2007-02-20
HUP0400159A2 (hu)	2004-07-28
UA75412C2 (en)	2006-04-17
ATE378318T1 (de)	2007-11-15
ES2295360T3 (es)	2008-04-16
CY1107427T1 (el)	2012-12-19
PE20021066A1 (es)	2003-01-21
CZ20033361A3 (cs)	2004-05-12
RU2004100302A (ru)	2005-04-10
ZA200308520B (en)	2004-09-06
US20050137200A1 (en)	2005-06-23
EE05196B1 (et)	2009-08-17
CR7140A (es)	2004-04-15
WO2002100825A3 (fr)	2003-12-11
RS97703A (en)	2006-12-15
CA2450076C (fr)	2010-11-30
DE50211213D1 (de)	2007-12-27
EE200300558A (et)	2004-02-16

Publication	Publication Date	Title
BG108415A (en)	2004-07-30	Anthranilic acid amides with a heteroarylsulphonyl side chain, method for the preparation thereof, their use as medicamentous or diagnostical form and pharmaceutical preparations containing the said compounds.
TNSN03084A1 (en)	2005-12-23	Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof
TWI256950B (en)	2006-06-21	Indanyl-substituted benzenecarboxamides, processes for their preparation, their use as a medicament and pharmaceutical formulations containing them
HK1066539A1 (en)	2005-03-24	Ortho-substituted nitrogen-containing bisaryl compounds use as potassium channel inhibitors
CY1106178T1 (el)	2011-06-08	2’- υποκατεστημενα 1,1’-διφαινυλο-2-καρβοξαμιδια, μεθοδος για την παρασκευη τους, η χρηση τους ως φαρμακου καθως και φαρμακευτικα παρασκευασματα που τα πepιεχουν
YU42503A (sh)	2006-05-25	Arilovani furan-1 tiofen-amidi-karbonske kiseline sa blokirajućim dejstvom kalijumovog kanala
MX9604378A (es)	1997-03-29	Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
CA2396561A1 (fr)	2001-07-05	Oxazolidinones substituees et leur utilisation dans le domaine de la coagulation sanguine
AU5477990A (en)	1990-11-29	Azaindenes
FR2856294B1 (fr)	2005-08-05	Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
RU95111308A (ru)	1996-12-27	Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
IL111036A (en)	1999-07-14	Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
BR0206791A (pt)	2004-01-27	Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
CA2152998A1 (fr)	1996-01-02	Composition pharmaceutique anti-hyperglycemique
ATE110714T1 (de)	1994-09-15	Derivate von hydroxaminsäure die lipoxygenase hemmen.
JP2001048801A5 (ja)	2005-11-04	経口用メラニン生成抑制組成物及び美白効果を有する食品
CA2001568A1 (fr)	1991-03-22	Medicament pour traiter la toxoplasmose
MXPA05009763A (es)	2006-01-27	2-(butil-1-sulfonilamino)-n-[1 (r)-(6-metoxipiridin-3-il) propil] benzamida, su uso en forma de un farmaco y preparaciones farmaceuticas que contienen a dicho compuesto.
UA41326C2 (uk)	2001-09-17	Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
WO2023154804A3 (fr)	2023-09-21	Méthode de traitement d'une lésion de la moelle épinière et composition correspondante
WO2024006974A3 (fr)	2024-04-11	Composés antipaludiques
BG106025U (en)	2003-04-30	Medicamentous form
RU96120655A (ru)	1998-12-10	Композиция для профилактики и лечения гриппа и орви